DNA methylation may partly explain psychotropic drug-induced metabolic side effects: results from a prospective 1-month observational study

DNA methylation may partly explain psychotropic drug-induced metabolic side effects: results from a prospective 1-month observational study

Abstract Background Metabolic side effects of psychotropic medications are a major drawback to patients’ successful treatment. Using an epigenome-wide approach, we aimed to investigate DNA methylation changes occurring secondary to psychotropic treatment and evaluate associations between 1-month met...

Full description

Bibliographic Details
Main Authors: Céline Dubath, Eleonora Porcu, Aurélie Delacrétaz, Claire Grosu, Nermine Laaboub, Marianna Piras, Armin von Gunten, Philippe Conus, Kerstin Jessica Plessen, Zoltán Kutalik, Chin Bin Eap
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Clinical Epigenetics
Subjects:
DNA methylation
Metabolic side effects
Psychotropic drugs
EWAS
Online Access:https://doi.org/10.1186/s13148-024-01648-4

Internet

https://doi.org/10.1186/s13148-024-01648-4

Similar Items